Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAMMA-AM in Chronic Wounds and Ocular Disorders
NCT07466576Phase 1Active, not recruiting
- Sponsor
- Biotechnology Research Center
- Start
- Nov 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in diabetic foot ulcer (DFU), corneal ulcer and pterygium, sponsored by Biotechnology Research Center. Primary endpoint: Number of participants with complete wound healing at 2 months. Started Nov 2025; status: active, not recruiting.
02
Conditions
diabetic foot ulcer (DFU)corneal ulcerpterygium
Beyond the preview
Go deeper on NCT07466576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07466576.